Take Action

H247 is a vaccine consumer protection bill that is currently stalled in the Vermont House Healthcare committee. The bill is really important but will die unless the committee chooses to pass it before March 2, 2018.
Here’s why the House HealthCare Committee should prioritize H247.
  1. H247 would provide an annual wrap-up of VAERS (vaccine reaction reports) from Vermonters.  This bill is critically important to protect consumers and is not “just for those who have vaccine injured children”!!
  2. As Ziba Kashef reported on May 9, 2017 about the recent Journal of the American Medical Association (JAMA) study: “Nearly one out of every three drugs approved by the Food and Drug Administration (FDA) have a new safety issue detected in the years after approval, says a Yale-led study. While most of the safety concerns are not serious enough to require withdrawal of a drug from the market, the finding highlights the need for ongoing surveillance of new drugs in the post-market period, said the researchers.”
Photo credit: National Journal 
3.   Drug makers have no liability when it comes to vaccines – and yet parents are forced to use the products on their children (unless they file a parent vaccine exemption).
4.   The Heath Department and pediatricians deny that vaccine injuries occur.

5. Lawmakers need to see the data on consumer injuries so they can better understand the impacts of the Vermont vaccination program and policy.

H247 was introduced in 2017 and has tri-partisan support. The bill is currently stalled in Vermont’s House Healthcare Committee and is not being considered as a priority by members off the committee.
NOTE: Contact committee members by phone or in person only.